Nikolai Kley
Chief Executive Officer at Orionis Biosciences BV
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Steve Gullans | M | 71 |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.
Orionis Biosciences BV
Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | - |
Jan Tavernier | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | - |
Carl W. Schafer | M | 75 |
Princeton University
| - |
Harold T. Shapiro | M | 89 |
Princeton University
| 36 years |
Stephen Pacala | M | 67 |
Princeton University
| 32 years |
Griet Vanpoucke | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.
Orionis Biosciences BV
Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | 9 years |
Shirley Marie Tilghman | M | 78 |
Princeton University
| 38 years |
Louise Sams | F | 66 |
Princeton University
| - |
James H. Cohen | M | - |
Princeton University
| - |
Robert G. Petit | M | 64 |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 2 years |
Jill Janaína Otto | F | - |
Princeton University
| - |
John T. Groves | M | - |
Princeton University
| - |
Marc Bazin | M | - |
Princeton University
| - |
Jeremiah P. Ostriker | M | - |
Princeton University
| - |
David Botstein | M | 81 |
Princeton University
| - |
Lynda Clarizio | F | 63 |
Princeton University
| 17 years |
Ramona Romero | F | - |
Princeton University
| - |
Jaime Ayala | M | 60 |
Princeton University
| - |
Jean-Luc Boulnois | M | - |
Princeton University
| - |
Amy Alving | M | 61 |
Princeton University
| 5 years |
Kim Boyle | F | - |
Princeton University
| - |
José Alexandre Scheinkman | M | 76 |
Princeton University
| - |
Richard W. Thaler | M | - |
Princeton University
| - |
William Happer | M | - |
Princeton University
| - |
Marcella Kanfer Rolnick | F | - |
Princeton University
| - |
Edward William Felten | M | 61 |
Princeton University
| - |
Alan S. Blinder | M | - |
Princeton University
| - |
Matias de Tezanos | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 6 years |
Stephen Kieran | M | - |
Princeton University
| - |
Leonard Wantchekon | M | - |
Princeton University
| - |
Rodney Priestley | M | - |
Princeton University
| - |
Kyle Keller | M | - |
Princeton University
| - |
Chad Maisel | M | - |
Princeton University
| - |
David Spergel | M | - |
Princeton University
| - |
Randall Kennedy | M | - |
Princeton University
| - |
Jonathan Levav | M | 49 |
Princeton University
| - |
Wei Xiong | M | 48 |
Princeton University
| 17 years |
Juan Ignacio Cirac Sasturain | M | 59 |
Princeton University
| - |
Kimberly Johnson | F | 51 |
Princeton University
| - |
Sharad Malik | M | 59 |
Princeton University
| - |
James Timberlake | M | - |
Princeton University
| - |
Joshua Rabinowitz | M | - |
Princeton University
| - |
Bonnie Bassler | M | 61 |
Princeton University
| 30 years |
Cecilia Elena Rouse | M | 60 |
Princeton University
| 32 years |
Andrew Bocarsly | M | - |
Princeton University
| - |
Sydney W. Kitson | M | - |
Princeton University
| - |
Christopher Chyba | M | - |
Princeton University
| - |
June M. Archer | F | - |
Princeton University
| 13 years |
Larry Peterson | M | - |
Princeton University
| - |
Hsien Pin Lee | M | 66 |
Princeton University
| - |
James A. Leach | M | 81 |
Princeton University
| 17 years |
James Shinn | M | - |
Princeton University
| - |
Andrea Goldsmith | M | 59 |
Princeton University
| 4 years |
Arnold Levine | M | 84 |
Princeton University
| 40 years |
Lisa N. Drakeman | M | 70 |
Princeton University
| - |
Dennis Keller | M | 82 |
Princeton University
| - |
John Diekman | M | 81 |
Princeton University
| - |
Morton Collins | M | 88 |
Princeton University
| - |
Juanita James | F | 71 |
Princeton University
| - |
Irvine O. Hockaday | M | 88 |
Princeton University
| - |
Nancy Peretsman | F | 70 |
Princeton University
| - |
Ann Korologos | F | 82 |
Princeton University
| - |
Robert Hugin | M | 69 |
Princeton University
| - |
Heidi Miller | M | 70 |
Princeton University
| - |
James N. Kyranos | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 8 years |
Joshua Bolten | M | 70 |
Princeton University
| - |
Franklin H. Moss | M | 75 |
Princeton University
| - |
Anthony Fadell | M | 55 |
Orionis Biosciences BV
Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | 1 years |
Richard Miles | M | 81 |
Princeton University
| 52 years |
Anne-Marie Slaughter | M | 65 |
Princeton University
| - |
Adel Mahmoud | M | 82 |
Princeton University
| 17 years |
Mark Jung | M | 61 |
Princeton University
| - |
Richard L. Grubman | M | - |
Princeton University
| - |
Thomas Siebel | M | 71 |
Princeton University
| - |
Daniel C. Tsui | M | 85 |
Princeton University
| - |
Thomas Shenk | M | 77 |
Princeton University
| 40 years |
David F. McShea | M | - |
Princeton University
| 17 years |
Jaswinder Singh | M | 59 |
Princeton University
| - |
Carl Ferenbach | M | 82 |
Princeton University
| - |
Michele S. Warman | F | - |
Princeton University
| - |
Marta Tienda | M | 73 |
Princeton University
| 27 years |
Donald E. Kirkpatrick | M | - |
Princeton University
| - |
John Hepburn | M | 75 |
Princeton University
| - |
James M. Litvack | M | 82 |
Princeton University
| - |
Alain L. Kornhauser | M | - |
Princeton University
| - |
James R. Broach | M | 76 |
Princeton University
| 40 years |
Nancy H. Becker | F | - |
Princeton University
| - |
Malcolm Stevenson Forbes | M | 76 |
Princeton University
| - |
Michael E. Hogan | M | - |
Princeton University
| - |
Harold Poor | M | 72 |
Princeton University
| 10 years |
Kai Li | M | 61 |
Princeton University
| 38 years |
Matias de Tezanos | M | 44 |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 6 years |
Joe B. Alala | M | 53 |
Princeton University
| - |
Leon Kalvaria | M | - |
Princeton University
| - |
Robert Murley | M | 74 |
Princeton University
| - |
David G. Offensend | M | 69 |
Princeton University
| - |
Bihua Chen | F | 55 |
Orionis Biosciences BV
Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | 3 years |
Paul Maeder | M | 70 |
Princeton University
| 9 years |
J. Andrew Cowherd | M | 71 |
Princeton University
| - |
Max Branzburg | M | - |
Princeton University
| - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 98 | 98.00% |
Belgium | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nikolai Kley
- Personal Network